December 8, 2003Archives of Internal Medicine
Role of the Natriuretic Peptide System in Cardiorenal Protection
Key result
Targeting the natriuretic peptide system represents a new therapeutic strategy for potentially enhancing cardiorenal protection in patients with hypertension, diabetes, and heart or renal failure.
Population
Patients with chronic renal and cardiac failure, hypertension, and diabetes
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Should not yet change practice for cardiorenal protection; leaves open whether natriuretic peptide targeting improves outcomes.
Structured PICO
P
Population
Patients with chronic renal and cardiac failure, hypertension, and diabetes
I
Intervention
Therapeutic strategies targeting the natriuretic peptide system for cardiorenal protection
This review discusses the role of the natriuretic peptide system and neurohormonal factors in cardiorenal protection for patients with heart failure, renal failure, hypertension, and diabetes.
Cite This Study
McFarlane et al. (2003) conducted a review in Chronic renal and cardiac failure, hypertension, and diabetes. Natriuretic peptide system targeted therapies was evaluated. Targeting the natriuretic peptide system represents a new therapeutic strategy for potentially enhancing cardiorenal protection in patients with hypertension, diabetes, and heart or renal failure.